NASDAQ: YHGJ
YUNHONG GREEN CTI LTD.CIK 0001042187 · SIC 3060 · Fabricated Rubber Products, NEC
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (FUL 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade YHGJ commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 7, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Income (Loss) (Unaudited)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Net sales | 3,900,000 | 5,457,000 | 10,054,000 | 10,259,000 |
| Cost of sales | 3,362,000 | 4,479,000 | 8,502,000 | 8,415,000 |
| Gross profit | 538,000 | 978,000 | 1,552,000 | 1,844,000 |
| Operating expenses: | ||||
| General and administrative | 675,000 | 754,000 | 1,598,000 | 1,593,000 |
| Selling | 34,000 | 37,000 | 71,000 | 72,000 |
| Advertising and marketing | 149,000 | 168,000 | 302,000 | 338,000 |
| Total operating expenses | 858,000 | 959,000 | 1,971,000 | 2,003,000 |
| Income (loss) from operations | (320,000) | 19,000 | (419,000) | (159,000) |
| Other (expense) income: | ||||
| Interest expense | (225,000) | (227,000) | (467,000) | (465,000) |
| Other income/(expense) | 2,000 | 23,000 | 2,000 | 23,000 |
| Total other expense, net | (223,000) | (204,000) | (465,000) | (442,000) |
| Net loss | (543,000) | (185,000) | (884,000) | (601,000) |
| Deemed dividends on preferred stock | (43,000) | (43,000) | (86,000) | (86,000) |
| Net loss attributable to common shareholders | (586,000) | (228,000) | (970,000) | (687,000) |
| Basic income (loss) per common share | (0.22) | (0.09) | (0.37) | (0.26) |
| Diluted income (loss) per common share | (0.22) | (0.09) | (0.37) | (0.26) |
| Weighted average number of shares and equivalent shares of common stock outstanding: | ||||
| Basic | 2,608,638 | 2,608,082 | 2,604,856 | 2,608,082 |
| Diluted | 2,608,638 | 2,608,082 | 2,604,856 | 2,608,082 |
Condensed Consolidated Balance Sheets (Unaudited)
| Description | June 30, 2026 | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | 320,000 | 97,000 |
| Accounts receivable, net | 3,295,000 | 5,955,000 |
| Inventories | 7,827,000 | 8,738,000 |
| Prepaid expenses | 351,000 | 283,000 |
| Total current assets | 11,793,000 | 15,073,000 |
| Property, plant and equipment: | ||
| Machinery and equipment | 21,993,000 | 21,993,000 |
| Office furniture and equipment | 2,122,000 | 2,122,000 |
| Intellectual property | 783,000 | 783,000 |
| Leasehold improvements | 39,000 | 39,000 |
| Fixtures and equipment | 518,000 | 518,000 |
| Projects under construction | 170,000 | 140,000 |
| 25,625,000 | 25,595,000 | |
| Less: accumulated depreciation and amortization | (21,885,000) | (21,599,000) |
| Total property, plant and equipment, net | 3,740,000 | 3,996,000 |
| Other assets: | ||
| Operating lease right-of-use | 3,087,000 | 3,393,000 |
| Total other assets | 3,087,000 | 3,393,000 |
| TOTAL ASSETS | 18,620,000 | 22,462,000 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Trade payables | 1,482,000 | 1,677,000 |
| Line of credit | 4,591,000 | 6,822,000 |
| Notes payable current portion | 443,000 | 146,000 |
| Notes payable related party | 344,000 | 344,000 |
| Operating lease liabilities current portion | 659,000 | 596,000 |
| Advance investor deposits | 225,000 | 150,000 |
| Accrued liabilities | 627,000 | 950,000 |
| Total current liabilities | 8,371,000 | 10,685,000 |
| Long-term liabilities: | ||
| Notes payable net of current portion | - | 348,000 |
| Operating lease liabilities noncurrent | 2,526,000 | 2,873,000 |
| Total long-term liabilities | 2,526,000 | 3,221,000 |
| TOTAL LIABILITIES | 10,897,000 | 13,906,000 |
| SHAREHOLDERS’ EQUITY | ||
| Series E Preferred Stock no par value, 130,000 shares authorized, issued and outstanding at June 30, 2026 and December 31, 2025 (liquidation preference of $1,300,000) | 1,032,000 | 976,000 |
| Series F Preferred Stock no par value, 70,000 shares authorized, issued and outstanding at June 30, 2026 and December 31, 2025 (liquidation preference of $700,000) | 555,000 | 525,000 |
| Common stock no par value, 2,000,000,000 shares authorized, 2,613,670 and 2,601,788 shares issued and 2,609,244 and 2,597,362 shares outstanding at June 30, 2026 and December 31, 2025, respectively | 27,891,000 | 27,891,000 |
| Additional paid-in-capital | 7,676,000 | 7,711,000 |
| Accumulated deficit | (29,270,000) | (28,386,000) |
| Less: Treasury stock, 4,426 shares, at cost | (161,000) | (161,000) |
| TOTAL SHAREHOLDERS’ EQUITY | 7,723,000 | 8,556,000 |
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | 18,620,000 | 22,462,000 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | (884,000) | (601,000) |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||
| Depreciation and amortization | 286,000 | 322,000 |
| Equity compensation expense | 51,000 | 17,000 |
| Change in assets and liabilities: | ||
| Accounts receivable | 2,660,000 | 1,608,000 |
| Inventories | 911,000 | 313,000 |
| Prepaid expenses and other assets | (68,000) | 169,000 |
| Trade payables | (195,000) | (104,000) |
| Operating leases | 22,000 | 40,000 |
| Advance investor deposit | 75,000 | - |
| Accrued liabilities | (323,000) | (50,000) |
| Net cash (used in) provided by operating activities | 2,535,000 | 1,714,000 |
| Cash flows from investing activities: | ||
| Purchases of property, plant and equipment | (30,000) | (42,000) |
| Net cash (used in) provided by investing activities | (30,000) | (42,000) |
| Cash flows from financing activities: | ||
| Repayment of note payable | (51,000) | (42,000) |
| Net repayments on revolving line of credit | (2,231,000) | (1,832,000) |
| Net cash provided by (used in) financing activities | (2,282,000) | (1,874,000) |
| Net increase (decrease) in cash and cash equivalents | 223,000 | (202,000) |
| Cash and cash equivalents at beginning of period | 97,000 | 220,000 |
| Cash and cash equivalents at end of period | 320,000 | 18,000 |
| Supplemental disclosure of cash flow information and noncash investing and financing activities: | ||
| Cash payments for interest | 467,000 | 465,000 |
| Accretion of dividends on preferred stock | 86,000 | 86,000 |
| Conversion of advance received from investors into common stock | - | 1,050,000 |
| Common stock issued in exchange for rent due to Icy Mellon | - | 182,000 |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗